Roka Bioscience Inc (NASDAQ:ROKA), after opening its shares at the price of $3.55, jumped up 6.85% to close at $3.90 for the day. The stock moved on a traded volume of 51,065.00 shares, in comparison to 96,517.00 shares of average trading volume.
Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, declared recently that Dr. Erin Dreyling, Vice President, Research & Scientific Affairs at Roka Bioscience will be a panelist in two sessions to be held at the 40th Annual National Food Policy Conference in Washington, DC.
Dr. Dreyling will be a panelist in the session entitled Big Data and the Future of Food Safety on Tuesday April 11th, 2017 at 11:15 AM ET. Dr. Dreyling will also be a panelist on Wednesday, April 12th at 11:15 AM ET, in the session Food Industry Disruptors.
“I am anxious to take part in the National Food Policy Conference in order to raise awareness about the important role that advanced pathogen detection technologies can play in improving food safety,” said Dr. Dreyling.
The 52-week range for the stock is $2.95 and $16.00 and during the previous trading session the stock touched its highest price at $4.05. Its introductory price for the day was $3.55. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 8.24% where (SMA50) and (SMA200) are -6.44% and -33.43% respectively.
Halozyme Therapeutics, Inc (NASDAQ:HALO) reported the gain of 0.24% and closed at $12.67with the total traded volume of 536,278.00 shares. The stock’s opening price was $12.67. The company has a total market capitalization of $1.66B.
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the first quarter 2017 on Tues., May 9 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date, Halozyme will release financial results for the first quarter 2017 following the close of trading.
The 52-week price range of the stock remained $7.70 – $15.20, while during last trade its minimum price was $12.63 and it gained its highest price of $13.05. Company’s last 5 days shows down turn with a decline of -2.46%. The company shows its Return on Assets (ROA) value of -35.90%. The Return on Equity (ROE) value stands at 0.00%. While it’s Return on Investment (ROI) value is -45.80%.
Luminex Corporation (NASDAQ:LMNX) percentage change reduced -0.05 % to close at $ 18.48 with the total traded volume of 249,017.00 shares, more than average volume of 233,318.00. The Company’s year to date performance remained optimistic with the declining as it lost almost -8.35 %. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -19.98 %. During last trade its minimum price was $ 18.37 and it gained its highest price of $ 18.83. Luminex Corporation generated a return on investment of 3.40 % in past 12 months and return on equity of 3.50 % for similar period. The Company’s Net profit margin was 5.10 % while gross profit margin was 66.40 %.
Luminex Corporation (NASDAQ: LMNX) declared that it anticipates to report results for the first quarter ended March 31, 2017 on Monday, May 1, 2017. A press release announcing the results is planned for release after the close of trading on that date.
Administration will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2017 on May 1, 2017, at 4:30 p.m. Eastern time.